(2R)-2-(2-Aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic Acid Anilide | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

(2R)-2-(2-Aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic Acid Anilide
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Aarti Pharmalabs Mirabegron

Contact Supplier

Mirabegron

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Minakem Mirabegron

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

(2R)-2-(2-Aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic Acid Anilide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

75 API Suppliers, 32 USDMF, 2 CEP/COS, 13 EU WC, 30 KDMF, 25 NDC API, 60 Listed Suppliers, $ API Reference Price

75 API Suppliers
32 USDMF
2 CEP/COS
13 EU WC
30 KDMF
25 NDC API
60 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

58 Intermediate Suppliers

58 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

43 FDF Dossiers, 15 FDA Orange Book, 15 Europe, 2 Canada, 2 South Africa, 9 Listed Dossiers

43 FDF Dossiers
15 FDA Orange Book
15 Europe
2 Canada
2 South Africa
9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 25MG, TABLET, EXTENDED RELEASE;ORAL - 50MG

TABLET, EXTENDED RELEASE;ORAL - 25MG
TABLET, EXTENDED RELEASE;ORAL - 50MG

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 15 Regulatory FDF Prices, 8 Annual Reports

1 US Medicaid Prescriptions
15 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

17 APIs, 3 FDF Dossiers

17 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

24 US Patents, 8 Health Canada Patents

24 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

20 Others

20 Others

$ API Ref.Price (USD/KG) : 1,531 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

24 All

01 24APGDI

filter Patent Number Reset all filters

24 All

01 110058536*PED

02 28772315

03 110058536

04 410842780

05 210842780*PED

06 411707451

07 211707451*PED

08 212059409

09 412097189

10 28772315*PED

filter API Patent Reset all filters

24 All

01 24Blank

filter FDF Patent Reset all filters

24 All

01 7Y

02 17Blank

filter Expiration Date Reset all filters

24 All

01 22028-10-30

02 22029-04-30

03 142029-09-28

04 42030-03-28

05 12036-03-31

06 12036-09-30

Synnat Mirabegron

Product Main Page

01

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-30

US Patent Number : 8772315

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-2300

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-30

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-30

US Patent Number : 8772315

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-2300

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-30

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 10842780

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202611

Patent Use Code : U-3670

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 10842780

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202611

Patent Use Code : U-3670

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

05

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 12097189

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-2996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

06

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 12097189

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-2996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

07

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 12097189

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-3670

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

08

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 12097189

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-3670

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

09

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 11707451

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-2996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

10

APGDI

DCAT Week

Not Confirmed

APGDI

U.S.A

DCAT Week

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-28

US Patent Number : 11707451

Drug Substance Claim :

Drug Product Claim :

Application Number : 202611

Patent Use Code : U-2996

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-28

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!